The S&P 500 and the Nasdaq slipped from record highs on Tuesday as a series of downbeat earnings weighed on the indexes, while investors looked ahead to the U.S. Federal Reserve's policy meeting later in the day.

UnitedHealth shares continue to struggle after the company issued a fresh outlook for 2025, indicating revenue and adjusted earnings below Street forecasts.

"We still believe the most likely outcome is slow growth and firm inflation: Not a recession, but a backdrop where the adverse effects of trade and immigration controls on growth outweigh the boost from deregulation and fiscal largesse," Morgan Stanley strategist Michael Zezas wrote.

Bankers and traders returned to work on a somber Tuesday morning in Midtown Manhattan, New York's financial epicenter, one day after a shooting that killed several people, including a senior Blackstone executive.

Boeing’s second-quarter loss narrowed and revenue improved as the aircraft manufacturer delivered more commercial planes in the period.

Baker Hughes nears $13.6B deal to buy Chart Industries, displacing Flowserve - FT. Cadence to pay $140 million to U.S. for selling chip design tech to Chinese university.

Big tech is already hundreds of billions of dollars deep into AI, and it’s likely to get deeper this year. But Wall Street says some need to get more aggressive.

When Wall Street veteran Tom Lee speaks, investors listen. As head of research at Fundstrat Global Advisors, Lee has built a reputation for bold predictions and contrarian calls that often prove prescient.

Since January 2019, the 4-6-D has materialized 27 times. What’s more, in 62.96% of cases, the following week’s price action results in upside, with a median return of 3.49%. With ZIM stock closing at $16.55 on Monday, we can roughly estimate that the security may pop to around $17.13.

Retail investors are often late to Wall Street parties, only catching the rally once it's established and "smart money" is looking for the exit. But that doesn't appear to be the case this time around.